###begin article-title 0
Skin-Derived TSLP Triggers Progression from Epidermal-Barrier Defects to Asthma
###end article-title 0
###begin p 1
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: SD RK. Performed the experiments: SD MM MJH. Analyzed the data: SD MM. Contributed reagents/materials/analysis tools: MJH. Wrote the paper: SD RK.
###end p 1
###begin p 2
###xml 201 207 <span type="species:ncbi:9606">people</span>
A skin-derived cytokine with high systemic availability provides a mechanistic explanation for atopic march and highlights a potential therapeutic target for preventing the development of asthma among people with atopic dermatitis.
###end p 2
###begin p 3
###xml 1066 1068 1066 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1058 1068 1058 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 264 270 <span type="species:ncbi:9606">humans</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1540 1548 <span type="species:ncbi:9606">patients</span>
Asthma is a common allergic lung disease frequently affecting individuals with a prior history of eczema/atopic dermatitis (AD); however, the mechanism underlying the progression from AD to asthma (the so-called "atopic march") is unclear. Here we show that, like humans with AD, mice with skin-barrier defects develop AD-like skin inflammation and are susceptible to allergic asthma. Furthermore, we show that thymic stromal lymphopoietin (TSLP), overexpressed by skin keratinocytes, is the systemic driver of this bronchial hyper-responsiveness. As an AD-like model, we used mice with keratinocyte-specific deletion of RBP-j that sustained high systemic levels of TSLP. Antigen-induced allergic challenge to the lung airways of RBP-j-deficient animals resulted in a severe asthmatic phenotype not seen in similarly treated wild-type littermates. Elimination of TSLP signaling in these animals blocked the atopic march, demonstrating that high serum TSLP levels were required to sensitize the lung to allergic inflammation. Furthermore, we analyzed outbred K14-TSLPtg mice that maintained high systemic levels of TSLP without developing any skin pathology. Importantly, epidermal-derived TSLP was sufficient to trigger the atopic march, sensitizing the lung airways to inhaled allergens in the absence of epicutaneous sensitization. Based on these findings, we propose that in addition to early treatment of the primary skin-barrier defects, selective inhibition of systemic TSLP may be the key to blocking the development of asthma in AD patients.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 112 120 <span type="species:ncbi:9606">children</span>
###xml 157 163 <span type="species:ncbi:9606">people</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
Eczema (atopic dermatitis) is a common allergic skin inflammation that has a particularly high prevalence among children. Importantly, a large proportion of people suffering from eczema go on to develop asthma later in life. Although the susceptibility of eczema patients to asthma is well documented, the mechanism that mediates "atopic march"-the progression from eczema to asthma-is unclear. We used genetic engineering to generate mice with chronic skin-barrier defects and a subsequent eczema-like disorder. With these mice, we were able to investigate how skin-specific defects predisposed the lungs to allergic asthma. We identified thymic stromal lymphopoietin (TSLP), a cytokine that is secreted by barrier-defective skin into the systemic circulation, as the agent sensitizing the lung to allergens. We demonstrated that high systemic levels of skin-derived TSLP were both required and sufficient to render lung airways hypersensitive to allergens. Thus, these data suggest that early treatment of skin-barrier defects to prevent TSLP overexpression, and systemic inhibition of TSLP, may be crucial in preventing the progression from eczema to asthma.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 153 156 153 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Meyer1">[1]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Masoli1">[2]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel1">[3]</xref>
###xml 575 578 575 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel1">[3]</xref>
###xml 339 347 <span type="species:ncbi:9606">children</span>
###xml 496 504 <span type="species:ncbi:9606">patients</span>
###xml 813 821 <span type="species:ncbi:9606">patients</span>
Allergic asthma is a chronic lung disease characterized by T-helper2 (Th2)-mediated inflammation and airway obstruction in response to allergen exposure [1]. Asthma is an increasingly common disorder affecting more than 300 million individuals around the world [2]. Atopic dermatitis (AD) is another prevalent allergic disease, and 17% of children in the United States suffer from this disorder [3]. In comparison to its 4-8% prevalence in the general population, asthma develops in up to 70% of patients with history of severe AD, a phenomenon referred to as "atopic march" [3]. It may be possible to prevent asthma in these at-risk individuals by early diagnosis of AD and blockage of the atopic march. To achieve this, it is critical that we understand the mechanism triggering the development of asthma in AD patients.
###end p 7
###begin p 8
###xml 253 256 253 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Umetsu1">[4]</xref>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Morar1">[5]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Segre1">[6]</xref>
###xml 702 705 702 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel1">[3]</xref>
###xml 833 836 833 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Palmer1">[7]</xref>
###xml 837 840 837 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Ying1">[8]</xref>
###xml 865 868 865 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Rogers1">[9]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Marenholz1">[10]</xref>
###xml 981 985 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Weidinger1">[12]</xref>
###xml 1262 1266 1262 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel2">[13]</xref>
###xml 1306 1310 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Marenholz1">[10]</xref>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Palmer2">[11]</xref>
###xml 887 895 <span type="species:ncbi:9606">patients</span>
###xml 1114 1120 <span type="species:ncbi:9606">humans</span>
###xml 1257 1261 <span type="species:ncbi:10090">mice</span>
###xml 1274 1280 <span type="species:ncbi:9606">humans</span>
A survey of the literature has identified several possible mechanisms underlying the clinical link between AD and asthma. These include: (a) a systemic immune system disorder leading to excessive Th2 response at epithelial surfaces exposed to allergens [4], (b) a barrier defect shared by both skin and lung epithelia that leads to overstimulation of the immune cells by invading allergens [5], or (c) systemic consequences of a skin-specific barrier defect causing immune cells to mount an allergic inflammation at any allergen-exposed epithelial surface [6]. Epidemiological data supporting the third hypothesis include the observation that AD tends to be the first manifestation of the atopic march [3]. Another supportive observation relates to filaggrin, a skin cornified envelope protein that is absent from the lung epithelia [7],[8]. Although controversial [9], it seems that AD patients with filaggrin loss-of-function mutations exhibit increased incidence of asthma [10]-[12]. This is consistent with the third hypothesis, that loss of an epidermal-specific barrier protein can trigger systemic atopy in humans. Mechanistically, it is suspected that epicutaneous sensitization with allergens underlies the development of airway hyperreactivity in mice [13] and in humans with filaggrin mutations [10],[11]. However, it is unclear whether intrinsic skin-barrier defects can trigger asthma in the absence of any epicutaneous sensitization. If epicutaneous exposure is not required, it will imply that systemic factor(s) produced by AD skin may be involved in sensitizing the bronchial epithelia. Such factors will be important as therapeutic targets in preventing asthma.
###end p 8
###begin p 9
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Rangarajan1">[14]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Lubman1">[17]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Lubman1">[17]</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1169 1173 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1226 1230 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1362 1366 1362 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 1367 1371 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Leonard1">[22]</xref>
###xml 1437 1441 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 1623 1631 <span type="species:ncbi:9606">patients</span>
To address this question, we studied mice lacking Notch signaling in the skin. Skin keratinocytes are organized in highly interconnected basal, spinous, granular, and cornified layers, forming an elaborate barrier protecting the organism from the outside environment. One of the major molecular regulators of this structure is Notch signaling [14]-[16]. Notch is a transmembrane receptor interacting with ligands expressed on the surface of neighboring keratinocytes [16],[17]. Upon activation, sequential proteolysis of Notch releases its intracellular domain, which then translocates into the nucleus, binds to RBP-j (the DNA-binding partner of Notch), and activates downstream targets [17]. Keratinocyte-specific deletion of Notch signaling pathway components impairs epidermal differentiation, resulting in skin-barrier defects [15],[16]. We have recently shown that Notch signaling loss in the skin also triggers a severe neonatal B-lymphoproliferative disorder (B-LPD; [15]). This systemic disease is directly caused by elevated levels of thymic stromal lymphopoietin (TSLP) released into the circulation by Notch-deficient keratinocytes failing to differentiate [15]. TSLP, a general biomarker for skin-barrier defects [15], is an interleukin-7 (IL-7)-like cytokine produced by epithelial cells and is implicated in the pathogenesis of both AD and asthma [18]-[22]. TSLP expression is sustained as long as barrier defects persist [15]. Thus, the potentially high systemic availability of skin-derived TSLP and its central role in promoting asthma bring up the possibility that TSLP may be the factor predisposing AD patients to asthma.
###end p 9
###begin p 10
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Segre1">[6]</xref>
###xml 503 511 503 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre</italic>
###xml 539 548 539 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 523 548 523 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/flox</sup></italic>
###xml 563 571 563 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre</italic>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Pan1">[23]</xref>
###xml 875 884 875 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s001">Figure S1</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 1855 1859 1855 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1367 1371 <span type="species:ncbi:10090">mice</span>
###xml 1594 1609 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2047 2055 <span type="species:ncbi:9606">patients</span>
Identifying a clear mechanism for the atopic march in the complex network of genetic, immunological, and environmental factors that contribute to AD has been a challenge to the field and has resulted in much debate as to the right therapeutic approach for preventing asthma [6]. To determine the mechanisms underlying the progression from AD to asthma, we first generated animals that lacked Notch signaling in a portion of their skin surfaces by embryonic removal of RBP-j from keratinocytes using the Msx2-Cre transgene (Msx2-Cre/+;RBP-jflox/flox or RBP-jCKO). Msx2-Cre is ectopically expressed at embryonic day 9.5 (E9.5) in clusters of ectodermal cells, resulting in a chimeric pattern of RBP-j deletion in the skin [23]. The presence of unaffected skin surfaces allowed RBP-jCKO animals to live for approximately 100 days on average with a few surviving up to one year (Figure S1) [15],[16], presenting a model in which to determine whether a defective skin-barrier could cause AD-like symptoms and render susceptibility to asthma in the absence of epicutaneous sensitization. We found that defective skin-barrier function in adult RBP-j-deficient animals caused the development of an AD-like allergic inflammation and a subsequent susceptibility to asthma. To determine whether TSLP is required for this susceptibility, we deleted the TSLP receptor in RBP-jCKO mice and showed that this genetic manipulation blocked the development of asthma in animals with persistent AD-like pathology and inflammation. To ask if TSLP overexpression by skin keratinocytes is sufficient, we used outbred transgenic mice overexpressing TSLP in epidermal keratinocytes and showed that epidermal-derived TSLP was sufficient to confer a severe asthmatic phenotype even in the absence of any skin defect. These findings establish that high systemic availability of TSLP [15] can sensitize the lung to allergens, and provide a novel molecular mechanism for the atopic march. Serum TSLP is thus an important potential therapeutic target in preventing asthma in AD patients.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 9 13 <span type="species:ncbi:10090">Mice</span>
RBP-jCKO Mice Develop an AD-Like Skin Phenotype
###end title 12
###begin p 13
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 628 637 628 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s002">Figure S2</xref>
###xml 642 650 642 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s009">Table S1</xref>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Blanpain1">[16]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Kuramoto1">[24]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Aberg1">[25]</xref>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Segre1">[6]</xref>
###xml 751 754 751 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Palmer1">[7]</xref>
###xml 1231 1243 1231 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g001">Figure 1A&#8211;1C</xref>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 1272 1276 <span type="species:ncbi:10090">mice</span>
###xml 1286 1292 <span type="species:ncbi:9606">humans</span>
The ablation of Notch signaling in skin keratinocytes by removing RBP-j severely impairs the differentiation of basal layer keratinocytes and maintenance of upper spinous and granular cell layers [15],[16]. Such a defect in epidermal stratification leads to an aberrant skin-barrier function signified by transepidermal water loss and penetration of dye through the defective barrier in RBP-j-deficient mice at birth [15],[16]. After birth, the persistence of barrier defects in RBP-j-deficient skin is evident by the presence of reactive epidermal hyperplasia, TSLP overexpression, and up-regulation of antimicrobial peptides (Figure S2 and Table S1) [15],[16],[24],[25]. Defective skin-barrier function has been suggested to be a hallmark of AD [6],[7]. In agreement with this notion, the impaired skin-barrier function in RBP-jCKO mice initiated an inflammatory cascade culminating in the development of an AD-like skin phenotype. The hyperplastic epidermis, acanthosis, hyperkeratosis, parakeratosis, and mast cell infiltration were evident in RBP-jCKO skin as early as 1 wk after birth, followed by dramatic dermal mast cell accumulation, serum IgE elevation, and systemic Th2 cell expansion in adult RBP-j-deficient animals (Figure 1A-1C). Therefore, adult RBP-jCKO mice resemble humans with AD to a degree that allows us to examine the systemic consequences of an allergic inflammation in the skin.
###end p 13
###begin title 14
###xml 9 13 <span type="species:ncbi:10090">mice</span>
RBP-jCKO mice lacking RBP-j (and thus, notch signaling) in skin keratinocytes develop a progressive, AD-like disease culminating in aged animals with lung inflammation.
###end title 14
###begin p 15
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Yamamoto1">[42]</xref>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
(A) H&E and Toluidine blue staining of the skin documents severe AD-like changes in RBP-j-deficient mice, including epidermal hyperkeratosis, parakeratosis, acanthosis, skin inflammation, and increased number of dermal mast cells (insets) detectable as early as 1 wk after birth, which worsen as RBP-jCKO animals age (6 wk and 10 wk). Note that the keratin cysts formed in the dermis of RBP-jCKO mice are due to the destruction of RBP-j-deficient hair follicles [42]. (B) The progression of skin inflammation is reflected in RBP-jCKO serum IgE levels, which are dramatically elevated by 10 wk of age (10 wk; n = 4 for each group; *p<0.01). (C) Intracellular cytokine staining of CD4+ T cells isolated from lymph nodes (mixture of inguinal and axillary) or spleen shows a robust interleukin (IL)-4-positive and interferon (IFN)-gamma-negative Th2 cell presence in 10-wk-old RBP-jCKO animals, indicating the development of a full-blown AD-like allergic inflammation. Percentage of cells in each quadrant is included (representative data are presented). (D) H&E and periodic acid-Schiff (PAS) staining of the lung do not show any signs of inflammation in 10-wk-old RBP-jCKO animals; however, at 52 wk (1 y), the mutant mice develop lung inflammation. The pathology of RBP-jCKO lung includes immune cell infiltration around the airways and blood vessels (arrowheads), goblet cell hyperplasia in the airways (arrow; insets), and airway remodeling (representative pictures are presented; scale bar: 50 microm).
###end p 15
###begin title 16
AD-Like Skin Disease Predisposes RBP-jCKO Animals to Allergic Asthma
###end title 16
###begin p 17
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g001">Figure 1D</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 666 674 666 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g002">Figure 2</xref>
###xml 1063 1079 1063 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g002">Figure 2A and 2B</xref>
###xml 1251 1260 1251 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g002">Figure 2C</xref>
###xml 1622 1631 1622 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g002">Figure 2D</xref>
###xml 1651 1656 1651 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 1685 1695 1685 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s003">Figures S3</xref>
###xml 1700 1702 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s007">S7</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 533 539 <span type="species:ncbi:9606">humans</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1412 1416 <span type="species:ncbi:10090">mice</span>
The lungs of 10-wk-old mice with RBP-j-deficient skins were normal and did not show any sign of allergic inflammation under standard housing conditions; however, the longest-living mutant animals (52 wk) did develop spontaneous lung inflammation (Figure 1D). To determine whether this phenotype was a true indicator of increased susceptibility to an asthmatic phenotype, we used an ovalbumin (OVA)-induced model of allergic inflammation with 5- to 7-wk-old RBP-jCKO mice. This protocol faithfully mimics the development of asthma in humans [18]. OVA-treated RBP-jCKO animals developed a more severe lung inflammation compared with OVA-treated wild-type littermates (Figure 2). Although the wild-type animals tolerated the intranasal OVA challenge well, two out of ten OVA-treated RBP-jCKO mice died during this procedure following a period of severe labored breathing. In the surviving mutants, the number of bronchoalveolar lavage (BAL) leukocytes and the percentage of BAL eosinophils were significantly higher compared with those of the wild-type littermates (Figure 2A and 2B). The absolute number of eosinophils was approximately 7-fold higher in the mutant mice. In addition, IgE was detectable only in the BAL fluid of RBP-j-deficient animals (Figure 2C). Histology of the lungs from OVA-challenged RBP-jCKO and wild-type controls clearly confirmed the existence of severe airway inflammation in RBP-jCKO mice, including significant leukocyte infiltration around the airways and blood vessels, extensive goblet cell hyperplasia in the large airways, and distinct appearance of goblet cells in medium-sized airways (Figure 2D). Considering that RBP-j is not deleted in the lung (Figures S3 and S7), these data clearly show that the skin-barrier defect can serve as a primary risk factor for development of asthma in a normal lung.
###end p 17
###begin title 18
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 98 104 <span type="species:ncbi:10090">murine</span>
Five- to seven-wk-old RBP-jCKO mice develop a severe allergic lung inflammation in an OVA-induced murine model of asthma.
###end title 18
###begin p 19
###xml 207 213 207 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 191 213 191 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/+</sup></italic>
###xml 220 229 220 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 215 229 215 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox/flox</sup></italic>
###xml 236 242 236 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/+</sup>
###xml 231 242 231 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox/+</sup></italic>
###xml 1091 1092 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1114 1115 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
(A and B) There are more leukocytes (A) and a higher percentage of eosinophils (B) present in BAL fluid collected from OVA-treated RBP-jCKO mice in comparison to their wild-type littermates (Msx2-Cre/+;RBP-jflox/+, RBP-jflox/flox, RBP-jflox/+), indicating a severe airway inflammation in these mutant animals (M, macrophages; E, eosinophils; L, lymphocytes; N, neutrophils). (C) IgE reaches detectable levels only in BAL fluid from RBP-j-deficient mice, further indicating the high intensity of OVA-induced allergic inflammation in the RBP-jCKO lung. (D) Comparing lung histology of RBP-jCKO with wild-type littermates sensitized and challenged with OVA shows a significantly more intense lung inflammation in RBP-jCKO mice. H&E and PAS staining shows greater immune cell infiltration around the airways and blood vessels (arrowheads), increased airway remodeling, goblet cell hyperplasia (insets), and mucus overproduction in the mutant lung (representative pictures are presented; scale bar: 50 microm). "Controls" refers to RBP-jCKO and wild-type animals treated with PBS instead of OVA (n = 4 for each group; *p<0.05, comparing the adjacent groups). These data are confirmed in additional independent experiments.
###end p 19
###begin title 20
TSLP Signaling Is Required for the Atopic March in RBP-j-Deficient Animals
###end title 20
###begin p 21
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel1">[3]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Yoo1">[26]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Palmer2">[11]</xref>
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 785 794 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s002">Figure S2</xref>
###xml 920 924 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-AlShami1">[19]</xref>
###xml 930 934 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Huston1">[21]</xref>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
It is possible that atopic skin lesions are the essential components downstream of skin-barrier defects that initiate systemic atopy in RBP-jCKO mice [3]. If this hypothesis were true, Th2 cells generated at the site of inflamed skin would migrate to other sites, including lung mucosa, and release high levels of Th2-derived cytokines, which would sensitize the lung airways to allergic inflammation. This model, however, is challenged by findings that show that Th2 cells generated in mouse models of AD specifically home to skin [26]. In addition, it is unclear whether the presence of AD lesions is required for initiation of the atopic march [11]. Skin-barrier defects led to systemic TSLP elevation [15], which remained elevated in the serum of RBP-jCKO animals throughout life (Figure S2). On the basis of these observations and that localized TSLP overexpression in lung epithelium is capable of inducing asthma [18],[19],[21], we have articulated an alternative hypothesis: TSLP may be a systemic signal that sensitizes the animals to allergen exposure in the lung. In that case, high systemic levels of epidermal-derived TSLP should render RBP-jCKO animals susceptible to the asthmatic phenotype upon exposure to allergen.
###end p 21
###begin p 22
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 95 105 91 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+</italic>
###xml 111 120 107 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 106 120 102 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox/flox</sup></italic>
###xml 121 125 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7r</italic>
###xml 160 164 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Park1">[27]</xref>
###xml 204 209 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLPR</italic>
###xml 256 261 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 502 506 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-He1">[28]</xref>
###xml 635 651 615 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3A and 3B</xref>
###xml 816 825 792 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3A</xref>
###xml 830 839 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s004">Figure S4</xref>
###xml 867 871 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 1031 1047 999 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3C and 3D</xref>
###xml 1162 1166 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1327 1331 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-He1">[28]</xref>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
To test this hypothesis we deleted the IL7Ralpha subunit of TSLP receptor in RBP-jCKO animals (Msx2-Cre/+;RBP-jflox/flox;IL7ralpha-/-; or RBP-jCKO;IL7ralpha-/- [27]). This strategy was chosen because the TSLPR subunit of the TSLP receptor is linked to the RBP-j locus. The inhibition of TSLP reception reduced the severity of local AD-like inflammation in the skin of RBP-jCKO animals as judged by the reduction of dermal mast cells in RBP-jCKO;IL7ralpha-/- mice relative to their RBP-jCKO littermates [28]. However, a significant elevation in mast cell number was still detectable in RBP-jCKO;IL7ralpha-/- skin compared to wild type (Figure 3A and 3B). In addition, epidermal hyperplasia and TSLP overexpression that mark the presence of postnatal skin-barrier defects persisted in aged RBP-jCKO;IL7ralpha-/- mice (Figure 3A and Figure S4). Importantly, deletion of IL7Ralpha did not affect the intensity of systemic Th2 response to allergic skin inflammation and serum IgE levels remained elevated in RBP-jCKO;IL7ralpha-/- mice (Figure 3C and 3D). This could be due to other cytokines/chemokines made by defective skin barrier in RBP-jCKO;IL7ralpha-/- animals [15], which together with exposure to allergens/pathogens through the compromised skin, sustain a robust systemic Th2 response even in the absence of TSLP reception [28]. Therefore, RBP-jCKO;IL7ralpha-/- animals provide a suitable system in which to determine if skin-barrier defects and AD-like skin inflammation including a systemic Th2 response with its consequences (e.g., elevated IgE) could confer susceptibility to asthma in the absence of TSLP signaling.
###end p 22
###begin title 23
###xml 64 68 <span type="species:ncbi:10090">mice</span>
TSLP signaling blockade rescues asthmatic phenotype of RBP-jCKO mice.
###end title 23
###begin p 24
###xml 373 377 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-He1">[28]</xref>
###xml 706 707 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 854 863 826 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 838 868 810 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/flox</sup>;IL7r</italic>
###xml 873 876 841 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/-</italic>
###xml 895 896 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1868 1872 1808 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 2612 2613 2524 2525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2635 2636 2547 2548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 1371 1375 <span type="species:ncbi:10090">mice</span>
###xml 1929 1933 <span type="species:ncbi:10090">mice</span>
###xml 2091 2095 <span type="species:ncbi:10090">mice</span>
###xml 2483 2487 <span type="species:ncbi:10090">mice</span>
(A) H&E and Toluidine blue staining of the skin shows the persistence of epidermal hyperplasia, hyperkeratosis, parakeratosis, and acanthosis in 10-wk-old RBP-jCKO;IL7ralpha-/- skin. However, the local skin inflammation and number of dermal mast cells (insets) are markedly reduced in RBP-jCKO;IL7ralpha-/- skin (representative pictures are presented; scale bar: 50 microm [28]). (B) The quantitative analysis of mast cell infiltration in the dermis of RBP-jCKO;IL7ralpha-/- (R;I) shows that there is still more mast cell accumulation in RBP-jCKO;IL7ralpha-/- compared to wild-type (Wt) and IL7ralpha-/- (I) skin. The bar graphs show the average number of mast cells in ten random 100x microscope fields (*p<0.001). (C) Serum IgE levels of 10-wk-old RBP-jCKO;IL7ralpha-/- mice are highly elevated and are comparable to those of RBP-jCKO (Msx2-Cre/+;RBP-jflox/flox;IL7ralpha+/-, R) littermates (*p<0.01). (D) Intracellular cytokine staining shows a significant population of IL-4-producing Th2 cells in inguinal/axillary lymph nodes and spleen of 10-wk-old RBP-jCKO;IL7ralpha-/- animals (representative data are presented). (E) Comparing lung histology of 5- to 7-wk-old RBP-jCKO;IL7ralpha-/-, RBP-jCKO, IL7ralpha-/-, and wild-type littermates sensitized and challenged with OVA shows a complete reversal of the intense RBP-jCKO lung inflammation in RBP-jCKO;IL7ralpha-/- mice. H&E and PAS staining shows the muted inflammatory response around the airways and blood vessels (arrowheads), and lack of airway remodeling or goblet cell hyperplasia (insets) in RBP-jCKO;IL7ralpha-/- lung (representative pictures are presented; scale bar: 50 microm). (F and G) The average number of leukocytes (F) and percentage of eosinophils (G) in BAL fluid from OVA-treated RBP-jCKO;IL7ralpha-/- lung is lower than that of wild-type lung treated similarly, indicating that deletion of IL7Ralpha rescues the allergic lung inflammation in RBP-jCKO mice (M, macrophages; E, eosinophils; L, lymphocytes; N, neutrophils). (H) IgE remains below detection levels in BAL fluid from OVA-treated RBP-jCKO;IL7ralpha-/- mice, further confirming that the intense OVA-induced allergic inflammation in RBP-jCKO lung is absent in RBP-jCKO;IL7ralpha-/- lung. To avoid death among RBP-jCKO cohort, all the animals in this study are challenged intranasally with OVA twice. Although the asthmatic response among RBP-jCKO;IL7ralpha-/-, IL7ralpha-/-, and wild-type groups is minimal, a severe response is seen in RBP-jCKO mice. "Controls" refers to RBP-jCKO;IL7ralpha-/-, RBP-jCKO, IL7ralpha-/-, and wild-type animals treated with PBS instead of OVA (n = 4 for each group; *p<0.01, compared to wild-type cohort). These data are confirmed in additional independent experiments.
###end p 24
###begin p 25
###xml 410 422 394 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3E&#8211;3H</xref>
###xml 583 592 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3E</xref>
###xml 751 767 723 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3F and 3G</xref>
###xml 862 871 830 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3H</xref>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
We challenged the lung airways of age- and sex-matched RBP-jCKO;IL7ralpha-/-, RBP-jCKO;IL7ralpha+/- (RBP-jCKO), IL7ralpha-/-, and wild-type littermates with OVA. To prevent RBP-jCKO lethality, all the animals in this experiment received intranasal OVA challenges only twice. Despite this reduced exposure, RBP-jCKO animals developed a severe asthmatic response, which was absent in RBP-jCKO;IL7ralpha-/- mice (Figure 3E-3H). Histological analysis could not detect goblet cell hyperplasia or significant inflammation around the airways and vasculature in RBP-jCKO;IL7ralpha-/- lungs (Figure 3E). Total white blood cell count and eosinophilia in BAL fluid from OVA-treated RBP-jCKO;IL7ralpha-/- mice was indistinguishable from IL7ralpha-/- littermates (Figure 3F and 3G). In addition, IgE was undetectable in BAL fluid from OVA-treated RBP-jCKO;IL7ralpha-/- mice (Figure 3H). These findings show that without a TSLP signal, no progression from allergic skin inflammation to asthma is observed, indicating that atopic march requires TSLP signals.
###end p 25
###begin title 26
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
Airway Hyper-Responsiveness in RBP-jCKO Mice Is Blocked by Inhibiting TSLP Signaling
###end title 26
###begin p 27
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 748 756 740 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g004">Figure 4</xref>
###xml 890 898 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g004">Figure 4</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
Airway hyper-responsiveness is a hallmark of allergic asthma [18]. To determine whether skin-derived TSLP could cause airway hyper-responsiveness in RBP-jCKO mice, we used the OVA-induced model of allergic inflammation and challenged the lung airways of age- and sex-matched RBP-jCKO;IL7ralpha-/-, RBP-jCKO, IL7ralpha-/-, and wild-type littermates twice with OVA. Thereafter, we measured the total lung resistance of OVA-treated mice at basal state (vehicle alone) or in response to increasing doses of nebulized methacholine. As expected, OVA-treated RBP-jCKO mice mounted a more severe airway resistance compared with their wild-type littermates when exposed to low doses of methacholine, and could not tolerate the higher doses of methacholine (Figure 4). RBP-jCKO;IL7ralpha-/-, however, did not develop any significant airway resistance even when exposed to high doses of methacholine (Figure 4). These results confirm that skin-barrier defects predispose animals to asthmatic phenotypes and that TSLP is required for this predisposition.
###end p 27
###begin title 28
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Severe airway hyper-responsiveness among OVA-treated RBP-jCKO mice is dependent on TSLP signaling.
###end title 28
###begin p 29
###xml 139 147 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figure 3</xref>
###xml 358 359 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 361 362 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 744 745 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Age- and sex-matched RBP-jCKO;IL7ralpha-/-, RBP-jCKO, IL7ralpha-/-, and wild-type littermates are sensitized and challenged with OVA as in Figure 3. Airway reactivity at the basal state (vehicle alone; V) and in response to increasing doses of methacholine (2.5, 5, 10, 20, 40, and 80 mg/ml) is monitored in OVA-treated animals using total lung resistance (RL; n = 4 for each group). OVA-treated RBP-jCKO animals mount a severe airway hyper-responsiveness at 5 mg/ml of methacholine and do not tolerate methacholine doses less than or equal to 10 mg/ml, developing fatal labored breathing. OVA-treated RBP-jCKO;IL7ralpha-/-, IL7ralpha-/-, and wild-type mice, on the other hand, show moderate response only to the highest dose of methacholine (*p<0.01). Data are presented as mean + standard deviation of percent increase in total lung resistance compared to basal state (vehicle alone; V) in each group. These measurements are confirmed in another independent set of experiments.
###end p 29
###begin title 30
TSLP Overexpression by the Skin Is Sufficient to Trigger the Atopic March
###end title 30
###begin p 31
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Yoo1">[26]</xref>
###xml 424 426 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 416 426 416 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g005">Figure 5</xref>
###xml 573 582 573 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s005">Figure S5</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Whitehead1">[29]</xref>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 662 672 662 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 836 845 836 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g005">Figure 5B</xref>
###xml 940 942 940 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 932 942 932 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1055 1057 1055 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1047 1057 1047 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1139 1155 1139 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g005">Figure 5C and 5D</xref>
###xml 1185 1187 1185 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1177 1187 1177 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 284 289 <span type="species:ncbi:10090">mouse</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1188 1192 <span type="species:ncbi:10090">mice</span>
Although we showed that TSLP signaling is necessary for the development of asthma in RBP-j-deficient animals with chronic allergic skin inflammation, it remains unclear whether other factors associated with AD-like skin lesions contribute to this atopic march. TSLP overexpression in mouse skin led to an AD-like pathology on an inbred background [26]. However, we discovered that on an outbred background, the same K14-TSLPtg mice [15] maintained high serum TSLP levels under normal conditions (approximately 450 pg/ml) without any skin or lung inflammation (Figure 5 and Figure S5) [29]. Normal skin morphology and the lack of mast cell hyperplasia evident in K14-TSLPtg mice confirmed that in this outbred background and in the absence of skin-barrier defects, TSLP overproduction was insufficient to attract mast cells to the skin (Figure 5B). In addition, serum IgE levels and Th2 cell numbers in the peripheral lymph nodes of K14-TSLPtg mice were indistinguishable from the wild type, confirming the absence of allergic skin inflammation in K14-TSLPtg animals that were not exposed to any external stimulus (e.g., allergen exposure; Figure 5C and 5D). Therefore, outbred K14-TSLPtg mice constituted a suitable model in which to examine whether epidermal TSLP overexpression alone would increase susceptibility to asthma upon allergen exposure.
###end p 31
###begin title 32
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
K14-TSLPtg mice exhibit no sign of skin or lung allergic inflammation under normal conditions.
###end title 32
###begin p 33
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 284 286 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 276 286 276 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 354 355 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 452 454 452 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 444 454 444 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 538 540 538 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 530 540 530 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
(A) Skin-derived TSLP overexpression leads to high systemic TSLP levels in the serum of K14-TSLPtg mice (n = 10 for each group; *p<0.01). (B-D) Under normal conditions, skin TSLP overproduction on an outbred C57BL/6-CD1 background does not elicit any allergic inflammation in K14-TSLPtg mice. Note the normal skin histology (B), normal serum IgE levels (n = 10 in each group)(C), and normal number of peripheral IL-4-producing Th2 cells (D) in K14-TSLPtg mice at postnatal day 120 (P120). (E) H&E and PAS stained lung sections of K14-TSLPtg animals confirm that no inflammation or airway remodeling occurred at P120 (scale bar: 50 microm).
###end p 33
###begin p 34
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 70 80 70 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 248 258 248 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6</xref>
###xml 522 524 522 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 514 524 514 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 658 667 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6A</xref>
###xml 734 744 734 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s006">Figures S6</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s007">S7</xref>
###xml 830 832 830 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 822 832 822 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6B</xref>
###xml 984 993 984 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6C</xref>
###xml 1082 1084 1082 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1074 1084 1074 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1091 1100 1091 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6D</xref>
###xml 1165 1174 1165 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6E</xref>
###xml 1245 1246 1237 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1268 1270 1260 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1260 1270 1252 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1385 1387 1377 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1377 1387 1369 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1543 1552 1535 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6F</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 411 426 <span type="species:ncbi:10090">transgenic mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
###xml 1271 1275 <span type="species:ncbi:10090">mice</span>
###xml 1388 1392 <span type="species:ncbi:10090">mice</span>
Next, we sensitized and challenged the lung airways of 5- to 7-wk-old K14-TSLPtg mice and their age- and sex-matched wild-type littermates three times with allergen. As seen in OVA-treated RBP-jCKO animals exposed to three doses of intranasal OVA, K14-TSLPtg mice developed a severe asthmatic response and significant lethality, which were not seen in the control group (Figure 6). Two out of eight OVA-treated transgenic mice died during the intranasal challenge. Histological examination of lungs from surviving K14-TSLPtg animals revealed pronounced airway remodeling with goblet cell hyperplasia and inflammation around the lung airways and vasculature (Figure 6A), which were negative for TSLP expression prior to OVA treatment (Figures S6 and S7). Total leukocyte count was less than 5-fold higher in BAL fluid from K14-TSLPtg mice compared with similarly treated wild-type animals (Figure 6B), which was mainly due to a severe BAL fluid eosinophilia in the transgenic animals (Figure 6C). In addition, IgE reached detectable levels only in BAL fluid from OVA-treated K14-TSLPtg mice (Figure 6D), which also experienced significantly higher serum IgE levels (Figure 6E) (1.6 microg/ml versus 0.18 microg/ml in OVA-treated wild-type serum, p<0.05). Thus, K14-TSLPtg mice developed an intense Th2 response upon allergen exposure. In the airway reactivity test, OVA-treated K14-TSLPtg mice showed a severe airway hyper-responsiveness to low doses of nebulized methacholine, which was not seen among similarly treated wild-type littermates (Figure 6F).
###end p 34
###begin title 35
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 27 37 27 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
OVA treatment reveals that K14-TSLPtg mice are prone to asthmatic phenotype.
###end title 35
###begin p 36
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 184 194 184 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 485 487 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 477 487 473 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 755 757 751 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 747 757 743 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 849 851 845 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 841 851 837 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 895 896 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 918 919 914 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 986 987 982 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 1032 1034 1028 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 1024 1034 1020 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 1189 1190 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1212 1213 1208 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
(A) Histological analysis shows severe inflammatory cell infiltrates (arrowheads), airway remodeling, and goblet cell hyperplasia (arrow; insets) in the lung airways of 5- to 7-wk-old K14-TSLPtg animals that are sensitized and challenged with OVA, but not in similarly treated wild-type littermates (scale bar: 50 microm). (B-D) BAL fluid analysis shows more leukocytes (B), a higher percentage of eosinophils (C), and specific appearance of IgE in lung airways of OVA-treated K14-TSLPtg mice (D), confirming the higher intensity of the asthmatic phenotype conferred by the TSLP overexpression in the morphologically normal skin (M, macrophages; E, eosinophils; L, lymphocytes; N, neutrophils). (E) The severe allergic inflammation in OVA-treated K14-TSLPtg lungs leads to drastic elevation of serum IgE in the animals. "Controls" refers to K14-TSLPtg and wild-type mice treated with PBS alone (n = 4 for each group; *p<0.05, comparing the adjacent groups). (F) Total lung resistance (RL) measurements show that OVA-treated K14-TSLPtg lung airways are hyper-responsive to increasing doses of nebulized methacholine as compared to OVA-treated wild types (V: vehicle-only basal measurement; n = 4 for each group; *p<0.05). These findings are confirmed in additional independent experiments.
###end p 36
###begin p 37
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 20 30 20 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s008">Figure S8</xref>
###xml 299 307 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP</italic>
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 351 361 351 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 426 436 426 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s006">Figures S6</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio.1000067.s007">S7</xref>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
Even though outbred K14-TSLPtg animals developed a severe asthmatic phenotype, their skin retained its normal appearance after OVA treatment, confirming that the lung inflammation did not depend on a concurrent skin lesion (Figure S8). Although low levels of TSLP were expressed in the trachea, the K14-TSLP transgene was not expressed in the lung of K14-TSLPtg animals and TSLP protein was not detectable in their BAL fluid (Figures S6 and S7). Therefore, these observations are most consistent with a model in which systemic TSLP is sufficient to predispose mice to allergic lung inflammation.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 585 588 585 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Spergel1">[3]</xref>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Liu1">[20]</xref>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
This report describes the mechanism that mediates the progression of a local allergic skin disease to a disseminated allergic inflammation downstream of skin-barrier defects in mice. We show that creating an intrinsic skin-barrier defect (by removing Notch signaling specifically from some skin keratinocytes) results in the sensitization of the lung airways to allergens. Similar to the clinical cases, barrier-defective mice require a secondary insult by allergens to expose their predisposition to asthma. Importantly, we show that epicutaneous sensitization with a common allergen [3] is not required to achieve this pronounced lung hyper-responsiveness. Therefore, RBP-jCKO animals demonstrate that skin-barrier impairment provides a signal that promotes development of a distant atopy in the lung, most likely by a systemic, diffusible cytokine. We identified this signal to be TSLP, a central player in the early stages of allergic inflammation [18]-[20] and a barrier-defect-sensitive product of skin keratinocytes that is released prior to development of an AD-like skin lesion [15]. In contrast to TSLP overexpression by lung epithelia, which does not result in systemic accumulation of this cytokine [18], overexpression of TSLP in the skin results in high systemic availability [15]. Therefore, skin is capable of acting as a signaling organ, driving susceptibility to allergic inflammation in another barrier organ (i.e., lung) by releasing TSLP.
###end p 39
###begin p 40
###xml 597 599 593 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 589 599 585 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 752 756 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Liu2">[30]</xref>
###xml 766 770 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Rochman1">[31]</xref>
###xml 771 775 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Rochman2">[32]</xref>
###xml 795 799 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Reche1">[33]</xref>
###xml 1265 1269 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-GuttmanYassky1">[34]</xref>
###xml 1498 1502 1494 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-GuttmanYassky1">[34]</xref>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 1419 1427 <span type="species:ncbi:9606">patients</span>
Importantly, we were able to show that TSLP was necessary to predispose RBP-j-deficient animals to the asthmatic phenotype. Concomitant removal of IL7Ralpha subunit of the TSLP receptor in RBP-jCKO mice prevented the atopic march despite persistent AD-like pathology and elevated serum IgE levels. Complementing this experiment is the observation that overexpression of TSLP by skin keratinocytes leads to high serum levels of TSLP that are sufficient to sensitize the lung airways to allergic inflammation in the absence of any skin pathology. If the low levels of TSLP in the trachea of K14-TSLPtg mice contribute to the phenotype, they do so by adding to the already high levels of skin-derived serum TSLP. Because TSLP can activate dendritic cells [30], T cells [31],[32], and myeloid cells [33], we speculate that its high systemic levels directly prime these immune cells at distant sites (e.g., the lung) to mount an intense allergic inflammation in response to a second stimulatory signal (e.g., allergens in the lung airways); however, the specific contribution of these immune cells to the atopic march downstream of TSLP-mediated activation remains a subject for future investigation. Of note, elevated TSLP expression is also reported in psoriatic skin [34]; however, there is no evidence linking psoriasis to predisposition to asthma. This phenomenon could be explained by the dominance of Th1 response in patients with psoriasis and the unresponsiveness of their immune cells to TSLP [34].
###end p 40
###begin p 41
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Pourpak1">[35]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Galli1">[36]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Marenholz1">[10]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Palmer2">[11]</xref>
###xml 577 580 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Segre1">[6]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Soumelis1">[37]</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 472 480 <span type="species:ncbi:9606">patients</span>
###xml 615 623 <span type="species:ncbi:9606">patients</span>
###xml 681 686 <span type="species:ncbi:9606">human</span>
###xml 815 823 <span type="species:ncbi:9606">patients</span>
###xml 872 880 <span type="species:ncbi:9606">patients</span>
###xml 957 965 <span type="species:ncbi:9606">patients</span>
The findings outlined in this report have a potentially important implication for human health. They provide a plausible explanation of why a large number of AD patients develop asthma and other allergic disorders later in life [35],[36]. Because TSLP overproduction is triggered by skin-barrier defects and faithfully mirrors the severity of these defects [15], our data emphasize that an early and aggressive treatment of the underlying skin-barrier defects in AD-prone patients [10],[11] may be more beneficial in preventing asthma than treating the outbreaks of AD lesions [6]. Although serum TSLP levels in AD patients are yet to be determined, high TSLP expression levels in human AD lesions [37] suggest that this diffusible cytokine could also reach systemic levels sufficient to trigger atopic march in AD patients. If indeed serum TSLP levels are elevated in AD patients, our findings suggest that an aggressive management of TSLP levels in these patients will lower the incidence of asthma later in their lives.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 43
###begin p 44
###xml 16 25 16 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/flox</sup></italic>
###xml 54 63 54 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 38 69 38 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/flox</sup>; IL7r</italic>
###xml 107 115 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP</italic>
###xml 115 117 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</italic>
###xml 115 117 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>tg</italic></sup>
###xml 162 166 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 292 296 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Whitehead1">[29]</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Msx2-Cre/+;RBP-jflox/flox (RBP-jCKO), Msx2-Cre/+;RBP-jflox/flox; IL7ralpha-/- (RBP-jCKO;IL7ralpha-/-), and K14-TSLPtg mice were generated as previously described [15]. All animals were kept in mixed C57BL/6 and CD1 outbred genetic background, which are resistant to Th2-mediated inflammation [29]. Age- and sex-matched mutant and wild-type littermates were used in each analysis. All mice were maintained in the animal facility under Washington University animal care regulations.
###end p 44
###begin title 45
OVA Treatment
###end title 45
###begin p 46
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Zhou1">[18]</xref>
###xml 787 796 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g003">Figures 3</xref>
###xml 801 802 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g004">4</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">Mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
The allergic sensitization and lung airways challenge with OVA was carried out as previously outlined [18]. In brief, wild-type and mutant mice at 5-7 wk of age were sensitized on days 0 and 14 by 250 microl intraperitoneal injection of antigen solution containing 50 microg OVA (Sigma) dissolved in 1.3 mg aluminum hydroxide gel (Sigma) and PBS. On days 21, 22, and 23, mice were intranasally challenged with 150 microg OVA dissolved in 40 microl of PBS. Mice cohorts designated as "controls" included the mutant and wild-type animals that underwent the same regimen without OVA antigen. On day 24, all the animals were humanely euthanized for the analysis. To avoid mortality among RBP-jCKO animals, all the age- and sex-matched littermates used in the rescue experiments presented in Figures 3 and 4 were challenged only twice with OVA. Note that RBP-jCKO;IL7ralpha-/- mice could tolerate the repeated OVA intranasal challenge, but RBP-jCKO mice developed severe responses after even two exposures. The OVA experiments were conducted on male and female animals; however, within-sex analyses were performed to avoid any sex effect on phenotypes observed.
###end p 46
###begin title 47
Airway Reactivity Test
###end title 47
###begin p 48
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Martin1">[38]</xref>
###xml 321 329 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g004">Figure 4</xref>
###xml 416 418 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 408 418 408 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 434 442 434 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-1000067-g006">Figure 6</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Patel1">[39]</xref>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
The airway responsiveness to aerosolized methacholine was determined in OVA-treated animals by measuring total lung resistance and dynamic compliance as previously outlined [38]. In brief, mice were treated with OVA as described in the preceding section (two intranasal OVA challenges for all mice in rescue experiments (Figure 4) and three intranasal OVA challenges for all mice in sufficiency experiments (K14-TSLPtg and wild type; Figure 6)). The animals were then anesthetized for airway reactivity test on day 24 post OVA sensitization. They were ventilated through a tracheotomy and monitored for intrapleural pressure using an oroesophageal tube. PBS (vehicle) or methacholine (Sigma) in PBS were delivered at 3-min intervals using an in-line nebulizer. The respiratory flow signals were collected between deliveries using a pneumotach (SenSym SCXL004, Buxco Electronics). For detailed description of the device, refer to [39].
###end p 48
###begin title 49
Histology
###end title 49
###begin p 50
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 567 570 <span type="species:ncbi:10116">rat</span>
Dorsal skin samples were harvested from the mice and fixed in 4% PFA at 4 degreesC overnight. Lungs were inflated through the trachea to 25-cm water pressure with 4% PFA prior to excision from the chest and fixation. These lungs were PFA-fixed for 24 hr at 4 degreesC and embedded in paraffin. The paraffin-embedded tissues were sectioned at 5-6 microm and stained with hematoxylin and eosin (H&E), toluidine blue, or periodic acid-Schiff (PAS). For RBP-j immunohistochemical staining, anti-RBP-j antibody (clone T6709, Institute of Immunology) and biotinylated anti-rat secondary antibody were used. HRP-conjugated streptavidin and DAB substrate kit (Pierce) were used to visualize the signal. Hematoxylin was used to counterstain the sections. For TSLP immunostaining, paraffin-embedded tissue samples and biotinylated anti-TSLP antibody (R&D Systems) were used. Sections were counterstained with DAPI nuclear stain.
###end p 50
###begin title 51
BAL Analyses
###end title 51
###begin p 52
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
BAL fluid was collected by infusing the lungs of the anesthetized mouse with 1-ml PBS through tracheal insertion of a Surflo catheter (Terumo Medical). Leukocyte count in BAL fluid was determined using a Hemavet 950 analyzer (Drew Scientific). BAL fluid was spun down and the supernatant was stored for cytokine/immunoglobulin analysis. The cell pellet was resuspended in PBS and used for differential cell count after Giemsa staining on the slide.
###end p 52
###begin title 53
ELISA
###end title 53
###begin p 54
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">Mouse</span>
Serum TSLP levels were determined using Quantikine mouse TSLP kit according to manufacturer's instructions (R&D Systems). Serum and BAL fluid IgE levels were measured using Mouse IgE ELISA kit (Immunology Consultants Laboratory).
###end p 54
###begin title 55
Flow Cytometry
###end title 55
###begin p 56
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Yoo1">[26]</xref>
###xml 604 608 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Ong1">[40]</xref>
Intracellular cytokine staining was conducted to estimate Th2 cell census as previously described [26]. Single cell suspensions were prepared from spleen and lymph node samples and cultured in presence of PMA (50 ng/ml), ionomycin (1 microg/ml) and monensin (10 microg/ml) for 4 h. Cells were then stained with phycoerythrin (PE)-cy7 conjugated anti-CD4 antibody (552775, BD Bioscience Pharmingen). After fixation in 2% PFA and permeabilization with 0.5% saponin, cells were stained with PE conjugated anti-IL4 (554389) and APC conjugated anti-IFN-gamma (554412) antibodies from BD Bioscience Pharmingen [40].
###end p 56
###begin title 57
PCR
###end title 57
###begin p 58
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 315 320 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</sup>
###xml 310 320 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>&#916;</sup></italic>
###xml 339 343 335 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox</sup>
###xml 334 343 330 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox</sup></italic>
###xml 356 361 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 379 416 375 412 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTTTGCCACCAGAATCTGTTTGTTATTTGC-3&#8242;</named-content>
###xml 421 457 417 453 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTTGCTTGAGGCTTGATGTTCTGTATTGC-3&#8242;</named-content>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Conventional PCR for the RBP-j allele was performed on genomic DNA isolated from skin and lung of adult RBP-jCKO mice using KlenTaq10 (DNA Polymerase Technology) supplemented with 1.3 M final concentration of betaine (amplification cycles = 32). The following primers were used to distinguish between deleted (RBP-jDelta) and floxed (RBP-jflox) alleles of RBP-j: Deleted allele: 5'-TGTTTGCCACCAGAATCTGTTTGTTATTTGC-3' and 5'-ATTTGCTTGAGGCTTGATGTTCTGTATTGC-3'.
###end p 58
###begin p 59
###xml 15 52 15 52 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTTTGCCACCAGAATCTGTTTGTTATTTGC-3&#8242;</named-content>
###xml 57 92 57 92 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTACCTGGTACTAACTGTCTGGGACCG-3&#8242;</named-content>
Floxed allele: 5'-TGTTTGCCACCAGAATCTGTTTGTTATTTGC-3' and 5'-AGGTACCTGGTACTAACTGTCTGGGACCG-3'.
###end p 59
###begin title 60
qRT-PCR
###end title 60
###begin p 61
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Lee1">[41]</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSLP</italic>
###xml 185 211 185 211 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGGCTACCCTGAAACTGA-3&#8242;</named-content>
###xml 216 242 216 242 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTGGAGATTGCATGAAGGA-3&#8242;</named-content>
mRNA isolated from P4 epidermis and lung of RBP-jCKO and wild-type littermates was used to perform qRT-PCR analysis as previously described [41]. The primers used to amplify TSLP were: 5'-CCAGGCTACCCTGAAACTGA-3' and 5'-TCTGGAGATTGCATGAAGGA-3'.
###end p 61
###begin title 62
Statistical Analysis
###end title 62
###begin p 63
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
###xml 463 465 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 455 465 449 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
The quantitative measurements were assessed using Student t-test as the test of significance and presented as mean +/- standard deviation in bar graph format. Our studies were conducted in outbred cohorts of animals; therefore, we used nested ANOVA to exclude any effect of between-family differences and make certain the significant differences observed were solely attributable to the gene removed (RBP-jCKO and RBP-jCKO;IL7ralpha-/-) or overexpressed (K14-TSLPtg).
###end p 63
###begin title 64
Accession Numbers
###end title 64
###begin p 65
The Genbank () accession numbers for proteins discussed in this article are as follows: RBP-j, NM_009035; TSLP, NM_021367.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
RBP-jCKO animals die prematurely due to their severe skin phenotype (p<0.001 compared to wild-type life span, log-rank test). A few mutant mice that survive up to one year (red circles), however, develop spontaneous lung inflammation.
###end p 67
###begin p 68
(78 KB TIF)
###end p 68
###begin p 69
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Serum TSLP levels in RBP-jCKO mice are highly elevated. TSLP overproduction is evident in RBP-jCKO serum at 1 wk after birth, reaching extreme levels in the adult animals (n = 4 for each group; *p<0.01, comparing the mutants to the wild-type littermates).
###end p 69
###begin p 70
(55 KB TIF)
###end p 70
###begin p 71
###xml 117 126 117 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 101 126 101 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre/+;RBP-j<sup>flox/flox</sup></italic>
###xml 148 157 148 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 143 157 143 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox/flox</sup></italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
Lung epithelium is normal in RBP-jCKO animals. (A) PCR analysis of DNA isolated from adult RBP-jCKO (Msx2-Cre/+;RBP-jflox/flox) and wild-type (RBP-jflox/flox) skin and lung shows that RBP-j locus is intact (i.e., RBP-j is not deleted) in the lung (Delta: deleted allele; M: molecular marker; S: skin; L: lung). (B) Immunohistochemical analysis for RBP-j protein confirms that RBP-j is present in the lung airway epithelium. Skin sections stained under the same condition are presented as controls (scale bar: 50 microm).
###end p 71
###begin p 72
(7.35 MB TIF)
###end p 72
###begin p 73
###xml 142 147 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j</italic>
###xml 201 205 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL7R</italic>
###xml 212 213 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 236 237 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
Serum TSLP levels of 10-wk-old RBP-jCKO;IL7ralpha-/- mice are highly elevated. This indicates that skin-barrier defects caused by the loss of RBP-j in epidermal keratinocytes persist in the absence of IL7Ralpha (n = 5 for each group; * p<0.01). Note that serum TSLP levels in RBP-jCKO;IL7ralpha-/- mice are consistently and significantly higher than in RBP-jCKO animals. We are currently investigating the underlying reason for this surge.
###end p 73
###begin p 74
(50 KB TIF)
###end p 74
###begin p 75
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 20 30 20 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
The ear and skin of K14-TSLPtg mice appear normal at P120. This emphasizes that in an outbred genetic background (C57BL/6 and CD1 mix) these transgenic animals do not develop any skin inflammation under normal conditions.
###end p 75
###begin p 76
(1.3 MB TIF)
###end p 76
###begin p 77
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 46 56 46 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14</italic>
###xml 257 259 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 249 259 249 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
There is no TSLP overexpression detectable in K14-TSLPtg lung airways or parenchyma. Because the K14 gene is expressed in basal cells located in the trachea, we analyzed mRNA levels by qRT-PCR on samples isolated from epidermis, trachea and lung of K14-TSLPtg and wild-type mice. This analysis shows that the K14-TSLP transgene is active in basal cells within the trachea, but the overall levels are 200-fold lower than those made by epidermal keratinocytes (***p<0.0000001 and *p<0.01 compared to wild type).
###end p 77
###begin p 78
(145 KB TIF)
###end p 78
###begin p 79
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 51 61 51 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
Lung epithelium does not overexpress TSLP in adult K14-TSLPtg, RBP-jCKO, or RBP-jCKO;IL7ralpha-/- animals. Immunofluorescence staining for TSLP protein (red) confirms that TSLP is overexpressed only in the epidermal keratinocytes of the mutant mice. All sections are stained under the same conditions. Dotted lines outline the basement membrane and asterisks highlight the epidermal keratin cysts present in RBP-jCKO skin (scale bar: 50 microm).
###end p 79
###begin p 80
(5.3 MB TIF)
###end p 80
###begin p 81
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 24 34 24 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 91 101 91 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup></italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 180 195 <span type="species:ncbi:10090">transgenic mice</span>
The skin of OVA-treated K14-TSLPtg mice remains normal. H&E and toluidine blue staining of K14-TSLPtg and wild-type skin show no significant signs of cutaneous inflammation in the transgenic mice (scale bar: 50 microm).
###end p 81
###begin p 82
(1.3 MB TIF)
###end p 82
###begin p 83
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Aberg1">[25]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.1000067-Demehri1">[15]</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Major antimicrobial peptides are overexpressed in postnatal epidermis of RBP-jCKO animals. This overexpression indicates the persistence of the skin-barrier defect in RBP-jCKO mice after birth [25]. Data are extracted from a microarray study on P9 epidermis of RBP-jCKO and wild-type littermates as previously described [15]. The fold increase of antimicrobial peptide mRNA in RBP-j-deficient epidermis relative to wild type is presented.
###end p 83
###begin p 84
(37 KB PDF)
###end p 84
###begin p 85
###xml 418 420 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tg</sup>
###xml 410 421 406 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K14-TSLP<sup>tg</sup>,</italic>
###xml 442 451 438 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2-Cre,</italic>
###xml 482 491 478 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox/flox</sup>
###xml 477 491 473 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBP-j<sup>flox/flox</sup></italic>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
The authors would like to thank Ms. Ahu Turkoz and Suzanne Swanson for their excellent technical assistance; Drs. Michael Walter and Adrian Shifren for numerous discussions and encouragement during the execution of these studies; and Drs. David Ornitz, Jeffery Miner, and Anne Bowcock and the members of the Kopan laboratory for careful reading of the manuscript. We thank Dr. Andrew Farr for IL7ralpha-/- and K14-TSLPtg, Dr. Gail Martin for Msx2-Cre, and Dr. Tasuku Honjo for RBP-jflox/flox mice.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
T cells and NKT cells in the pathogenesis of asthma.
###end article-title 87
###begin article-title 88
The global burden of asthma: executive summary of the GINA Dissemination Committee report.
###end article-title 88
###begin article-title 89
Atopic dermatitis and the atopic march.
###end article-title 89
###begin article-title 90
Asthma: an epidemic of dysregulated immunity.
###end article-title 90
###begin article-title 91
The genetics of atopic dermatitis.
###end article-title 91
###begin article-title 92
Epidermal barrier formation and recovery in skin disorders.
###end article-title 92
###begin article-title 93
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
###end article-title 93
###begin article-title 94
###xml 36 41 <span type="species:ncbi:9606">human</span>
Lack of filaggrin expression in the human bronchial mucosa.
###end article-title 94
###begin article-title 95
Filaggrin mutations confer susceptibility to atopic dermatitis but not to asthma.
###end article-title 95
###begin article-title 96
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march.
###end article-title 96
###begin article-title 97
###xml 74 82 <span type="species:ncbi:9606">children</span>
Filaggrin null mutations are associated with increased asthma severity in children and young adults.
###end article-title 97
###begin article-title 98
###xml 61 69 <span type="species:ncbi:9606">children</span>
Filaggrin mutations, atopic eczema, hay fever, and asthma in children.
###end article-title 98
###begin article-title 99
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.
###end article-title 99
###begin article-title 100
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation.
###end article-title 100
###begin article-title 101
Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity.
###end article-title 101
###begin article-title 102
Canonical notch signaling functions as a commitment switch in the epidermal lineage.
###end article-title 102
###begin article-title 103
Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data.
###end article-title 103
###begin article-title 104
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice.
###end article-title 104
###begin article-title 105
A role for TSLP in the development of inflammation in an asthma model.
###end article-title 105
###begin article-title 106
Thymic stromal lymphopoietin: master switch for allergic inflammation.
###end article-title 106
###begin article-title 107
Thymic stromal lymphopoietin: a potential therapeutic target for allergy and asthma.
###end article-title 107
###begin article-title 108
TSLP: finally in the limelight.
###end article-title 108
###begin article-title 109
gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis.
###end article-title 109
###begin article-title 110
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1.
###end article-title 110
###begin article-title 111
Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.
###end article-title 111
###begin article-title 112
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.
###end article-title 112
###begin article-title 113
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor.
###end article-title 113
###begin article-title 114
TSLP acts on infiltrating effector T cells to drive allergic skin inflammation.
###end article-title 114
###begin article-title 115
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Allergen-induced airway disease is mouse strain dependent.
###end article-title 115
###begin article-title 116
TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation.
###end article-title 116
###begin article-title 117
The role of thymic stromal lymphopoietin in CD8+ T cell homeostasis.
###end article-title 117
###begin article-title 118
###xml 73 78 <span type="species:ncbi:9606">human</span>
Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells.
###end article-title 118
###begin article-title 119
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.
###end article-title 119
###begin article-title 120
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.
###end article-title 120
###begin article-title 121
###xml 10 18 <span type="species:ncbi:9606">patients</span>
Asthma in patients with atopic dermatitis.
###end article-title 121
###begin article-title 122
Atopic dermatitis and asthma.
###end article-title 122
###begin article-title 123
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.
###end article-title 123
###begin article-title 124
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Pulmonary responses to bronchoconstrictor agonists in the mouse.
###end article-title 124
###begin article-title 125
Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members.
###end article-title 125
###begin article-title 126
Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition.
###end article-title 126
###begin article-title 127
Bi-compartmental communication contributes to the opposite proliferative behavior of Notch1-deficient hair follicle and epidermal keratinocytes.
###end article-title 127
###begin article-title 128
Notch/RBP-J signaling regulates epidermis/hair fate determination of hair follicular stem cells.
###end article-title 128
###begin title 129
Abbreviations
###end title 129
###begin p 130
atopic dermatitis
###end p 130
###begin p 131
bronchoalveolar lavage
###end p 131
###begin p 132
interleukin
###end p 132
###begin p 133
ovalbumin
###end p 133
###begin p 134
T-helper2
###end p 134
###begin p 135
thymic stromal lymphopoietin
###end p 135
###begin p 136
The authors have declared that no competing interests exist.
###end p 136
###begin p 137
SD and RK were supported by a grant from the National Institutes of Health-National Institute of General Medical Sciences (GM55479-10). MM was supported in part by Washington University and by the Toyobo Biotechnology Foundation Long-Term Research Grant and the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 137
###begin title 138
Note Added in Proof
###end title 138
###begin p 139
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
After this manuscript was accepted for publication, similar observations were reported by Zhang et al: Zhang Z, Hener P, Frossard N, Kato S, Metzger D, et al. (2009). Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci U S A 106: 1536-1541.
###end p 139

